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Abstract 
The stress response is essential for survival, but it can be detrimental when persistently 
activated during chronic stress. Therefore, the magnitude of the stress response must be 
finely-tuned in order to be adaptive. Indeed, an animal’s stress response system normally 
undergoes habituation that decreases responses to a repeated, familiar stressor. Importantly, 
the same animal still responds normally, or even becomes sensitized, to an unfamiliar (novel) 
stressor. This indicates that chronic stress simultaneously induces two opposing types of 
plasticity, one that underlies habituated responses and another that drives sensitized 
responses. The activation of the hypothalamic-pituitary-adrenal (HPA) axis — a hallmark of 
the stress response — relies on the release of corticotropin releasing hormone (CRH) from 
neuroendocrine neurons in the paraventricular nucleus of the hypothalamus (PVN). Our 
recent study found that, in a mouse model of habituation to a repeated stressor, the intrinsic 
excitability of CRH neurons decreases (representing a potential mechanism for habituation to 
a familiar stressor). In this thesis, we investigated a potential mechanism that enables a 
sensitized response to an unfamiliar stressor in the same habituation model. Considering that 
afferent glutamatergic synapses are the major excitatory inputs onto CRH neurons, we 
hypothesized that potentiation of these excitatory synapses represents a neural correlate for 
sensitized responses to an unfamiliar stressor. By using patch clamp electrophysiology, we 
studied glutamatergic synaptic transmission onto CRH neurons in ex vivo brain slices. In 
support of our hypothesis, we found that habituation to repeated stress potentiated glutamate 
synapses onto CRH neurons. More specifically, this potentiation manifested as a sensitization 
to cAMP signaling that facilitated the release of glutamate. Furthermore, we revealed that 
cAMP-induced facilitation of glutamate release was dependent on presynaptic 
hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels. This result identifies a 
possible mechanism that supports stress sensitization of the HPA axis and suggests a novel 
role for HCN channels in the PVN.  
Keywords: stress, sensitization, HPA axis, paraventricular nucleus of the hypothalamus, 
corticotropin releasing hormone, hyperpolarization-activated cyclic nucleotide-gated 
channels 
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Chapter 1  
1 Introduction 
1.1 The Stress Response 
The stress response is an essential survival mechanism that evolved to enhance an 
organism’s ability to respond when a threat is perceived. This emergency response — 
also referred to as the fight-or-flight response — involves the coordination of the nervous 
and endocrine systems to prime the animal to fight off an impending challenge or escape 
to safety. One important aspect of the stress response is the activation of the 
hypothalamic-pituitary-adrenal (HPA) axis and the subsequent release of stress hormones 
(glucocorticoids, GCs) into the bloodstream that have widespread physiological and 
psychological effects on the animal. While vital in life threatening situations, long-term 
activation of the stress response can be detrimental. For example, long-term elevated 
glucocorticoid levels have been implicated in immune system dysfunction, heart disease, 
diabetes, and psychological conditions such as depression and post-traumatic stress 
disorder (PTSD) (Lupien, McEwen, Gunnar, & Heim, 2009; McEwen, 2000). 
Fortunately, animals have an innate ability to fine-tune the magnitude of the response in 
accordance with the learned significance of a given stressor. Indeed, stress-induced 
activation of the HPA axis becomes less and less pronounced when an animal is 
repeatedly challenged by a predictable stressor (i.e., stress habituation). Importantly, the 
same animal still maintains its ability to respond normally, or even becomes sensitized, to 
a novel stressor. This points to complex forms of plasticity that allow the HPA axis to 
respond with opposing outputs (sensitization and habituation) depending on the stressor. 
These two forms of plasticity evolved to allow an animal to escape from the negative 
consequences of glucocorticoid actions when confronted with a non-threatening stressor, 
but to also maintain a response to unfamiliar (thus threatening) stressors that require 
glucocorticoids to support a full-blown stress response. 
It is important to emphasize that a sensitized stress response can be maladaptive and has 
been implicated in human psychopathologies, such as major depressive disorder, bipolar 
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disorder, anxiety, PTSD and psychosis (Harkness, Hayden, & Lopez-duran, 2015). For 
this reason, understanding the underlying neural mechanisms for this stress-induced 
plasticity is fundamental to advance our understanding of these diseases. Despite its 
importance, the neural mechanisms that support sensitization have not been identified. 
This project investigates the neural mechanisms that allow the stress response to 
overcome habituation and respond to novel or unfamiliar stressors. Here, we use a mouse 
model of chronic stress, repeated restraint stress (RRS), that has been shown to lead to 
HPA axis habituation to a repeated stressor (restraint) while responding normally (or in a 
sensitized manner) to a novel stressor. 
1.2 The HPA Axis 
The HPA axis is the neuroendocrine arm of the stress response that ultimately leads to the 
release of stress hormones to mobilize stored energy and prepare the body to respond to a 
stressor. It begins with neuroendocrine neurons in the paraventricular nucleus of the 
hypothalamus (PVN), which release corticotropin releasing hormone (CRH) into the 
hypophyseal portal circulation. CRH (in addition to other co-released secretagogues) 
stimulates the anterior pituitary to release adrenocorticotrophic hormone (ACTH) into the 
general circulation (Vale & River, 1977), which in turn, travels to the adrenal cortex and 
initiates the systemic release of glucocorticoids (GCs; Fig. 1.1).  
GCs have widespread physiological effects throughout the body. GCs (primarily cortisol 
in humans and corticosterone in animals) help the body to cope with a stressor by down-
regulating energy-demanding processes, such as growth, immune function and 
reproduction and divert energy towards metabolism to increase available glucose in the 
blood. In addition to these peripheral effects, GC receptors are widely expressed in the 
brain and act as a negative feedback at various locations along the stress pathway (e.g., 
PVN, hippocampus, prefrontal cortex), as well as mediate the cognitive and emotional 
changes associated with stress. Importantly, GCs play a role in mediating synaptic 
plasticity along stress regulatory neural circuits that allows for modification of future 
responses to stress (Sapolsky, Romero, & Munck, 2000). Although these changes are 
adaptive in the short-term, it is well known that chronic GC exposure can be detrimental 
(McEwen, 2000). For this reason, there must be mechanisms to control the plasticity of 
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the HPA axis and maintain the delicate balance between adaptive and detrimental stress 
responses.  
Due to the widespread actions of GCs, the HPA axis plays a role in regulating digestion, 
immune system function, sexuality, mood, and energy storage. Further, the HPA axis is 
under circadian control and can also be activated by non-traditional stressors, such as 
food intake (Dallman et al., 1987). However, for the purposes of this discussion, I will 
focus on HPA activity in response to stress.  
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Figure 1.1 The HPA axis 
Schematic diagram showing the HPA axis hormonal cascade. Neuroendocrine neurons in 
the PVN secrete CRH into the hypophyseal portal circulation. CRH travels to the anterior 
pituitary and stimulates the secretion of ACTH into the bloodstream. ACTH acts on the 
adrenal cortex to stimulate secretion of GCs, which act through negative feedback 
mechanisms on the pituitary, hypothalamus and upstream brain targets to limit further 
HPA axis activation.  
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1.3 The PVN 
1.3.1 Cell Types  
Neuroendocrine CRH neurons, the apex of the HPA axis, cluster in the PVN. However, 
the PVN is a heterogenous structure with a complex organization of multiple different 
cell types besides neuroendocrine CRH neurons. These are organized into three main 
categories: 1) magnocellular neuroendocrine neurons, which secrete oxytocin and 
vasopressin to the posterior pituitary; 2) parvocellular neuroendocrine neurons, that 
release CRH and other hormones to the anterior pituitary by way of the median eminence 
and hypophyseal portal circulation; and 3) parvocellular preautonomic neurons, that 
project to the brainstem and spinal cord to regulate the autonomic response to stress 
(Tasker & Dudek, 1991).  
These cell types can be distinguished based on the hormones they secrete but also by 
their electrophysiological properties. Differential ion channel expression between the 
three categories allows for identification by unique electrophysiological “fingerprints” 
(Fig. 1.2) in an ex vivo whole-cell patch clamp configuration (Luther et al., 2002; Luther 
& Tasker, 2000). Magnocellular neurons are characterized by a transient outward 
rectification upon depolarization from a hyperpolarized membrane potential (Fig. 1.2 B). 
This is mediated by voltage-gated A-type potassium (K+) channels (IA) and causes a 
delay to the onset of action potential firing (i.e., delay to first spike) (Tasker & Dudek, 
1991). Parvocellular preautonomic neurons exhibit a characteristic low-threshold spike 
upon depolarization from a hyperpolarized membrane potential (Fig. 1.2 D). This is due 
to the opening of low threshold-activated T-type Calcium (Ca2+) channels (IT). 
Parvocellular neuroendocrine neurons, which include CRH secreting cells, can be 
distinguished by their lack of outward rectification and a minimal low-threshold T-type 
Ca2+ component (Fig. 1.2 C) (Tasker & Dudek, 1991). Instead, depolarization of these 
neurons produces tonic firing. As these parvocellular CRH neurons form the apex of the 
HPA axis, they will be our focus of discussion in this study. It is important to note that 
parvocellular neuroendocrine neurons in the PVN can secrete other peptide hormones in 
addition to CRH, including: vasopressin, somatostatin, thyrotropin-releasing hormone, 
enkephalin, and vasoactive inhibitory peptide (Simmons & Swanson, 2009). Small 
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numbers of parvocellular neurons also synthesize and release growth-releasing hormone 
and dopamine. Recent advances in genetic mouse models allow for the precise 
identification of CRH-secreting parvocellular neurons, such as the CRH-reporter mouse 
line characterized by Wamsteeker Cusulin and colleagues (2013).  
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Figure 1.2 Electrophysiological fingerprints of cell types in the PVN 
(A) Current clamp protocol used by Luther and Tasker (2000) to differentiate between 
the three subtypes of neurons in the PVN. (B) Firing pattern of magnocellular PVN 
neurons, showing characteristic outward rectification (black arrow) upon depolarization 
due to A-type K+ channels (IA). (B) Parvocellular neurosecretory neurons (including 
CRH neurons) exhibit a lack of outward rectification (black arrow) and a minimal low 
threshold T-type Ca2+ component. (C) Parvocellular preautonomic neurons exhibit a low 
threshold-activated T-type Ca2+ channel component (IT; black arrow) following 
depolarization from a hyperpolarized membrane potential.  
Modified from “Voltage-gated currents distinguish parvocellular from magnocellular 
neurones in the rat hypothalamic paraventricular nucleus,” by J. A. Luther & J. G. 
Tasker. 2000.  The Journal of Physiology. 523(1): 193–209. Copyright (2000) The 
Journal of Physiology. Reprinted with permission.  
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1.3.2 Afferent Inputs to the PVN 
1.3.2.1 Overview 
The HPA axis can be activated by a wide variety of stress signals, including: visual, 
auditory, somatosensory and olfactory cues of a predator; somatosensory and humoral 
cues indicating pain, injury and inflammation; and psychological or emotional cues in 
anticipation of stress. To accommodate the numerous types of information capable of 
activating the HPA axis, the PVN is innervated by a wide variety of brain areas (Fig. 1.3). 
These afferent projections converge on CRH neurons and control their activation through 
different types of neurotransmitters and neuromodulators. It has been proposed that these 
different inputs transmit signals for distinct types of stress. Specifically, Herman and 
colleagues (2003), suggested that “real” stress and “perceived” stress are coded by 
distinct circuits. Here, “real” stress is defined as a physiological challenge or physical 
damage to the body (e.g., injury, pain, inflammation, loss of blood). This differs from 
“predicted” or “perceived” stress, which are stress responses mounted in anticipation of, 
rather than in reaction to, stimuli that signal threat to homeostasis. Accordingly, the 
authors propose that “real” stress involves direct innervation by brainstem and 
hypothalamic areas, whereas “perceived” stress has more involvement of limbic and 
forebrain afferents by way of relay sites such as the bed nucleus of the stria terminalis 
(BNST) (Herman et al., 2003). Importantly the precise roles of these afferents remain 
elusive as there is much overlap and intermixing within the PVN, making it technically 
difficult to study the physiological roles of afferents in isolation. In this section, we 
review the key inputs to parvocellular, putative neuroendocrine CRH neurons in the 
PVN. 
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Figure 1.3 Major inputs to the PVN 
Schematic diagram of the major inputs to the PVN. Abbreviations: AHA, anterior 
hypothalamus; ARC, arcuate nucleus; BLA, basolateral amygdala; BNST, bed nucleus of 
the stria terminalis; CeA, central amygdala; DMH, dorsomedial hypothalamus; Hc, 
hippocampus; LC, locus coeruleus; MeA, medial amygdala; MnPO, medial preoptic 
10 
 
nucleus; NTS, nucleus tractus solitarius; PBN, parabrachial nucleus; PVT, 
paraventricular thalamus; peri-fx, peri-fornical area; PFC, prefrontal cortex; Raphe, 
Raphe nuclei; VLM, ventrolateral medulla; vSub, ventral subiculum; ZI, zona incerta. 
 
Reprinted from “Stress-related synaptic plasticity in the hypothalamus,” by J. S. Bains, J. 
I. Wamsteeker Cusulin, & W. Inoue. 2015.  Nature Reviews. 16(7): 377–388. Copyright 
(2015) Nature Reviews. Reprinted with permission. 
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1.3.2.2 GABA 
Just over half of all synaptic terminals in the PVN are GABAergic (Decavel & van den 
Pol, 1992) and GABA terminals make the most synaptic contacts to CRH neurons 
(Johnson, Bains, & Watts, 2018). Indeed, the HPA axis is normally constrained by 
inhibition; a reduction in this tonic GABAergic drive (i.e., disinhibition) to CRH neurons 
activates the HPA axis (Hewitt & Bains, 2006), whereas injection of GABA agonists 
inhibit GC secretion following restraint stress (Cullinan, 1998). GABAergic projections 
arise from a variety of areas including: the posterior regions of the BNST (Cullinan, 
Herman, & Watson, 1993), dorsomedial hypothalamus (Cullinan et al., 1993), arcuate 
nucleus (Baker & Herkenham, 1995; Canteras, Simerly, & Swanson, 1995), medial 
preoptic nucleus (Viau & Meaney, 1996), anterior hypothalamus (Bali, Erdélyi, Szabó, & 
Kovács, 2005), peri-fornical area, and from peri-PVN GABA neurons that project to 
CRH neurons (Bowers, Cullinan, & Herman, 1998; Roland & Sawchenko, 1993). Many 
of these GABAergic projections to the PVN are believed to serve as important relay sites 
for the integration of stress signals from other brain areas (Herman, Mueller, & 
Figueiredo, 2004). For example, the posterior BNST sends predominant GABAergic 
projections to the PVN and integrates input from the central amygdala (Dong, Petrovich, 
& Swanson, 2001; Redgate & Fahringer, 1973), which conveys information about 
psychological stressors, as well as the medial amygdala (Cullinan et al., 1993), which is 
activated by systemic stressors.  
1.3.2.3 Glutamate 
Glutamatergic transmission is the predominant excitatory input to the PVN and is a 
crucial mediator of HPA axis activity (van den Pol, Wuarin, & Dudek, 1990). Injection of 
glutamate into the PVN causes ACTH release (Darlington, Miyamoto, Keil, & Dallman, 
1989), and injection of the glutamate receptor antagonist, kynurenate, into the PVN 
reduces HPA axis responses to restraint stress (Ziegler & Herman, 2000). About half of 
the terminals that appose CRH neurons are glutamatergic (Flak, Ostrander, Tasker, & 
Herman, 2009) and these are mostly non-somatic (Johnson et al., 2018). Glutamatergic 
synapses arise from a variety of areas including: periaqueductal gray, zona incerta, 
subfasicular nucleus, parabrachial nucleus, raphe nuclei, nucleus of the solitary tract, and 
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the ventrolateral medulla (Herman et al., 2003; Ziegler, Edwards, Ulrich-Lai, Herman, & 
Cullinan, 2012). Many of these projections are thought to co-release other 
neurotransmitters and peptides, such as noradrenaline, glucagon-like peptide, 
neuropeptide Y, but not GABA (Ziegler, Cullinan, & Herman, 2002). Glutamate acts on 
both pre- and postsynaptic ionotropic and metabotropic glutamate receptors. The 
ionotropic component is thought to be primarily mediated by AMPA and NMDA 
receptors; however, some studies have hinted towards a role for kainate action in the 
PVN: Evanson, Van Hooren, and Herman (2009) showed that injection of a specific 
kainate antagonist into the PVN increased release of ACTH and corticosterone and 
increased c-Fos immunoreactivity in the PVN, indicating the paradoxical inhibitory roles 
of kainite type glutamate receptors on PVN neurons’ excitability. Koenig and Cho (2005) 
showed that kainate receptor mRNA was upregulated following hypoglycemia stress. 
Interestingly, no electrophysiological evidence for kainate receptors in CRH neurons has 
been found, leading to the conclusion that the majority of PVN glutamate signaling is 
likely mediated by AMPA receptors.  
Changes in glutamatergic synapses are likely important for HPA axis activation as well 
as adaptation and plasticity following chronic stress (Evanson & Herman, 2015). It has 
been shown that NMDA receptors undergo stress-induced plasticity following chronic 
variable stress (Ziegler, Cullinan, & Herman, 2005), and acute immobilization (Bartanusz 
et al., 1995). Also, the marker for presynaptic glutamate vesicles (vesicular glutamate 
transporter 2; VGLUT2) is significantly increased following chronic variable stress, 
suggesting increased glutamatergic innervation (Flak et al., 2009). Similarly, RRS 
increased glutamatergic synaptic transmission to CRH neurons, as measured by an 
increased frequency of excitatory activity. Further, our lab has recently shown that 
chronic variable stress decreases glutamatergic synaptic multiplicity in CRH neurons, 
thereby dampening synaptic gain (Salter, Sunstrum, Matovic, & Inoue, 2018). Clearly, 
there is strong evidence that glutamate signaling plays an important role in the 
modulation of the HPA axis, but precise changes in their functions require further 
investigation. 
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1.3.2.4 Catecholamine 
A large portion of synaptic terminals in the PVN express markers for catecholamine 
containing vesicles (tyrosine hydroxylase and dopamine beta dehydroxylase); however, 
no adrenaline inputs have been discovered suggesting they likely secrete noradrenaline 
(Johnson et al., 2018). Noradrenaline inputs to the PVN originate from brainstem nuclei, 
specifically the ventral medulla, nucleus of the solitary tract, and locus coeruleus 
(Swanson & Sawchenko, 1983). These inputs are known to activate the HPA axis 
(Plotsky, Cunningham, & Widmaier, 1989) in response to both psychological (Kinzig et 
al., 2003) and physiological stressors (Herman et al., 2003). It has been proposed that 
noradrenergic terminals may co-release glutamate (Swanson & Sawchenko, 1983; Ulrich-
Lai & Herman, 2009).  
1.3.2.5 Serotonin 
Serotonin injection into the PVN increases ACTH and corticosterone secretion, and 
therefore can activate the HPA axis (Feldman, Newman, & Weidenfeld, 2000; Pan & 
Gilbert, 1992). Interestingly, there is only a small contribution of serotonergic fibers 
innervating the PVN directly (Swanson & Sawchenko, 1983), which arise from the raphe 
nuclei. There is a much higher density of serotonergic fibers in the area surrounding the 
PVN, suggesting serotonin may act on GABAergic interneurons to CRH neurons, or 
synapse on other excitatory inputs to CRH neurons, just outside of the parvocellular 
PVN. However, it is still possible that these serotonergic fibers innervate distal dendrites 
of CRH neurons that reach outside the borders of the parvocellular region. Although the 
precise anatomy of this pathway is still elusive, there is strong evidence that the 
serotonergic projection modulates HPA axis activity. Pharmacological lesions of the 
serotonergic input (either by 5-HT antagonism in the PVN or raphe nuclei) result in a 
blunted ACTH response to restraint stress and endotoxin-induced stress in rats 
(Jørgensen, Knigge, Kjær, Vadsholt, & Warberg, 1998). It is possible that this is 
mediated by direct action on CRH neurons, as electrophysiological data shows that 5-
HT2CR agonists cause CRH neuron depolarization and an increase in firing rate (Heisler 
et al., 2007) and 5-HT1BR/5-HT6R activation resulted in c-Fos activation (Tung, Hardy, 
Wheeler, & Belsham, 2012).  
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1.3.2.6 Dopamine 
The PVN is innervated by dopaminergic projections from the zona incerta (Cheung, 
Ballew, Moore, & Lookingland, 1998), which may co-release glutamate. Dopamine 
receptor mRNA for D1, D2, D3, D4 and D5 have all been found in the PVN (Bitner et 
al., 2006; Bouthenet et al., 1991; Fremeau et al., 1991; Gurevich & Joyce, 1999; Rivkees 
& Lachowicz, 1997) and dopaminergic terminals are located in close proximity to CRH 
neurons (Liposits & Paull, 1989) suggesting dopamine may regulate HPA axis responses. 
Indeed, systemic administration of dopamine increases CRH mRNA production in the 
PVN (Eaton, Cheung, Moore, & Lookingland, 1996) and activates the HPA axis 
(Borowsky & Kuhn, 1992).  
1.3.2.7 Summary 
Although much work has been done to define the anatomical connections in the PVN, the 
precise nature of specific projections and how they modulate subtypes of stressors is not 
fully understood. It is likely that different neuromodulators work synergistically and 
through heterosynaptic modulation to regulate other neurotransmitters within the PVN.   
1.4 Habituation 
A central characteristic of the stress response is that the experience of stress itself 
changes subsequent responses. This has been shown extensively through the phenomenon 
of stress habituation, i.e., the decrease in the magnitude of a response to a repeated 
stressor (Grissom & Bhatnagar, 2009). For example, acute exposure to restraint in rats 
produces a robust rise in plasma ACTH levels; however, repeated exposure to restraint 
stress leads to attenuated production of ACTH with each subsequent exposure (Aguilera, 
1994). Habituation has also been shown to occur in response to cold stress, novel 
environment, water immersion, noise exposure, handling, and ethanol (Grissom & 
Bhatnagar, 2009). 
The concept of habituation was first characterized in a pioneering study by Thompson 
and Spencer (1966), in which 9 criteria were outlined to determine whether a given 
phenomenon represents habituation, which they defined as a “decrement as a result of 
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repeated stimulation”. These criteria were revisited and confirmed in a more recent 
review by a panel of experts in the field (Rankin et al., 2009) and specifically analyzed in 
regards to stress habituation in the same issue (Grissom & Bhatnagar, 2009). Grissom 
and Bhatnagar found that HPA axis habituation meets the criteria for habituation, and the 
authors highlight some key features for HPA axis habituation. 1) The HPA axis 
habituates to psychological (i.e., “perceived”) stressors more so than physiological (i.e., 
“real”) stressors. Although HPA axis activation occurs in response to both psychological 
and physiological stressors, it is only psychological stressors that generate decrements in 
stress responses with repeated exposure. The predicted adaptive value of this is simple; 
the animal consistently mounts a response when it is physically (i.e., actually) 
experiencing challenges, for example, injury, inflammation and starvation, but is able to 
fine-tune the stress response to psychological (i.e., anticipated but not actually 
happening) challenges based on the learned significance of a stressor. 2) Habituation is 
stressor-specific. That is, habituation to one type of stressor (e.g., restraint in mice) does 
not decrease subsequent responses to other stressors. This characteristic is one line of 
evidence that distinguishes habituation from general GC negative feedback (a second is 
that habituation is still evident in animals that lack GC negative feedback following 
adrenalectomy (Jaferi & Bhatnagar, 2006)). In some cases, the HPA axis is actually 
primed or sensitized for novel stressors after undergoing habituation to a repeated stressor 
(Bhatnagar & Dallman, 1998).  
Grissom and Bhatnagar  (2009) also emphasized the importance of studying HPA axis 
habituation and its mechanisms as it is closely linked to psychological disorders. It has 
been suggested that depression and PTSD may involve a failure to habituate to chronic 
stress. Despite the importance of this knowledge, remarkably little is known about the 
neural mechanisms underlying habituation. Our lab has recently identified a possible 
mechanism that could support habituation of the HPA axis. Inoue, Matovic, and Salter, 
(2017) found that mice that have habituated to RRS show decreased intrinsic excitability 
of CRH neurons. Specifically, CRH neurons fire fewer action potentials in response to 
depolarizing current injections after chronic stress. A similar change in the intrinsic 
excitability has been reported in rats after 3 days of repeated restraint (Kusek, Tokarski, 
& Hess, 2013). As CRH neuron activation controls the activation of the HPA axis, this 
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decreased input-output relationship is in line with habituation of the HPA axis, which 
functionally manifests as a decreased HPA axis output in response to the same magnitude 
of stress-relevant input.  
1.5 Sensitization 
It is important to note that the same chronic stress paradigms that lead to habituation to a 
repeated (or familiar) stressor can cause enhanced (or normal) HPA responses to novel 
(unfamiliar) stressors. In other words, a key characteristic of stress habituation is that it is 
stressor specific. This conveys a survival advantage to habituation, as the animal can 
conserve energy and not mount a full-blown response to a familiar, (learned to be) 
unthreatening stressor but still maintain its ability to respond to a novel stressor that may 
be life threatening. Sensitization of HPA axis responses have been found to occur in a 
wide variety of stress paradigms. For example, exposure to chronic cold stress increases 
HPA responses to restraint stress (Bhatnagar & Dallman, 1998); habituation to RRS 
increases subsequent HPA responses to hypertonic saline challenge (Aguilera, 1994), 
ether stress (Hauger, Lorang, Irwin, & Aguilera, 1990) and swim stress (Melia, Ryabinin, 
Schroeder, Bloom, & Wilson, 1994); and chronic exposure to hypertonic saline elicits 
sensitization to ether stress (Kiss & Aguilera, 1993). Despite the detailed characterization 
of this phenomenon, the underlying neural mechanisms have not been determined. It has 
been proposed that sensitization may involve plasticity across brain areas upstream of the 
PVN. For example, in the prefrontal cortex of rats that were exposed to cold stress, 
subsequent tail shock caused a greater increase in dopamine and noradrenaline release 
when compared to naïve animals (Gresch, Sved, Zigmond, & Finlay, 1994). When 
animals mount a sensitized response, it is likely that the neural circuits upstream of CRH 
neurons are more active and synapses onto PVN CRH neurons are in higher activity state 
than during normal and habituated responses. In line with this idea, Kusek, Tokarski, and 
Hess (2013), found that RRS in rats increases the frequency of spontaneous excitatory 
postsynaptic currents (sEPSCs) to CRH neurons, suggesting a possible correlate for 
stress-induced sensitization. Overall, the underlying mechanisms for stress sensitization 
have not been identified.  
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1.6 Rationale, Hypothesis, Aims 
1.6.1 Rationale 
Animals can habituate at behavioural, hormonal, and neural levels to repeated mild stress; 
however, the HPA axis maintains its ability to respond to novel or unfamiliar stressors 
despite its habituated state. With respect to neuronal mechanisms, this dual modulation 
predicts that there are two types of plasticity that allow animals to mount habituated and 
sensitized responses. Despite years of work in the field, the neural correlates for these 
opposing types of plasticity remain unknown. Our group recently found that RRS causes 
a decrease in the intrinsic excitability of CRH neurons (Inoue et al., 2017) (Fig. 1.4), 
which represents a neural correlate for HPA axis habituation. In line with this, c-Fos 
immunoreactivity (a marker for recent neuronal activation) is reduced following RRS 
(Fig. 1.5, unpublished), further supporting the idea that habituation occurs at the level of 
CRH neurons. We have also obtained evidence that, in the same RRS model, a novel 
stressor (cold swim) induced normal c-Fos activation (Fig. 1.5) consistent with the 
stressor-specific nature of habituation. Importantly, this data indicates that the novel 
stressor drove normal c-Fos activation (i.e., excitation) in CRH neurons despite their 
decreased intrinsic excitability. Thus, our RRS paradigm provides a useful model to study 
plasticity mechanisms for sensitization that overcome the decreased excitability of CRH 
neurons and mount a normal (or possibly sensitized) stress response to a novel stressor.  
1.6.2 Hypothesis 
The activity of CRH neurons during stress is driven by the activity of their synaptic 
inputs, and glutamate synapses are the major excitatory input to CRH neurons.  
Hypothesis: RRS potentiates afferent glutamate synapses onto CRH neurons.  
 
1.6.3 Aims 
1. Characterize stress-induced glutamatergic synaptic plasticity in a mouse 
model of RRS. 
Experimental Approach 
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To examine properties of glutamatergic synapses onto CRH neurons and their 
plasticity following RRS, we obtained whole-cell patch clamp recordings from CRH 
neurons and examined spontaneous excitatory postsynaptic currents (sEPSCs) in 
brain slices from naïve and RRS mice.  
 
Predictions 
The potentiation of glutamate synapses manifests as a sensitization of these synapses 
to stimuli that drive synaptic activity (mimicking the neural activity that occurs when 
responding to a novel stressor). To this end, we stimulated the activity of glutamate 
synapses by application of the cAMP activator, forskolin, to brain slices. 
 
2. Identify the molecular mechanism by which stress alters glutamatergic 
synaptic activity.  
Experimental Approach 
To identify the molecular mechanisms that underlie the RRS-induced potentiation of 
glutamate synapses, we examined the detailed mechanisms by which forskolin 
stimulates glutamate synapses and tested whether these mechanisms are altered after 
RRS.  
 
Predictions 
We predict that molecular mechanisms mediating forskolin’s action on synaptic 
stimulation are altered after RRS.  
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Figure 1.4 CRH Neurons have decreased intrinsic excitability after RRS 
(A) Representative current clamp traces illustrating a reduction in the CRH neuron spike 
frequency after RRS (red) compared to naïve (blue). Firing elicited by a depolarizing step 
from a hyperpolarized membrane potential. (B) Plot showing the spike frequency for a 
given current injection. CRH neurons from RRS mice (red) show a lower spike frequency 
for each current step compared to naïve (blue). Adapted from Inoue et al. (2017) 
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Figure 1.5 CRH Neurons habituate to RRS but show normal activation to novel 
stress.  
(A) Schematic diagram of restraint stress tube (top) and stress timeline (bottom) for 
repeated and novel stressors for c-Fos immunoreactivity, a marker for recent neuronal 
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activation. RRS consisted of 21 days of 1 hour per day of restraint and a final episode of 
restraint on the 22nd day before c-Fos analysis.  In a second cohort of mice, 21 days of 
RRS was followed by cold swim stress on the 22nd day before c-Fos analysis. (B) 
Representative images of CRH neurons (red; top) and colocalization of CRH neurons and 
c-Fos immunohistochemistry (white; bottom) for no stress (control), the first day of RRS 
(Day 1 RRS), the final day of RRS-only condition (Day 22 RRS) and the RRS followed 
by swim stress condition (Novel Stress). CRH neurons show habituation (decreased c-Fos 
immunoreactivity) following 21 days of RRS but recover CRH activation in response to a 
novel stressor. Adapted from Ichiyama and Inoue (unpublished). 
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Figure 1.6 Hypothesis schematic diagram 
Schematic diagram illustrating our hypothesis: RRS potentiates afferent glutamatergic 
inputs to CRH neurons, which could overcome the decreased CRH neuron excitability 
when responding to a novel stressor. (A) In stress-naïve animals, acute stressors activate 
afferent synaptic inputs to CRH neurons, which increases their activity ultimately leading 
to HPA axis activation. (B) Following RRS, CRH neurons have decreased intrinsic 
excitability (a possible mechanism for habituation). We propose that a second form of 
plasticity occurs in parallel, such that RRS potentiates the afferent glutamatergic inputs to 
CRH neurons. This plasticity could support sensitization of the HPA axis.   
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Chapter 2  
2 Materials and Methods 
2.1 Animals 
All experimental procedures were approved by the University of Western Ontario Animal 
Use Subcommittee and University Council on Animal Care in accordance with the 
Canadian Council on Animal Care guidelines (2014-031). CRH reporter mice were bred 
by crossing homozygous CRH-IRES-Cre (Stock 012704, Jackson Laboratory) with 
homozygous ROSA26-tdTomato mice (Stock 007914, Jackson Laboratory) in the animal 
facility of the University of Western Ontario. The heterozygous offspring, as 
characterized in detail previously (Wamsteeker Cusulin et al., 2013), express tdTomato 
fluorescence in all CRH producing cells, which allowed for visual identification of PVN-
CRH neurons during electrophysiology experiments (Fig. 2.1). All mice used were 8–14-
week-old males and were group-housed (2–4 per cage) under a 12H:12H light:dark cycle 
(lights on at 07:00) with ad libitum access to food and water. Shoebox mouse cages were 
supplied with mouse housing, paper nesting materials and wood chip bedding, and cages 
were cleaned every 7 days. 
 
24 
 
 
Figure 2.1 Visual identification of CRH neurons 
In a slice electrophysiology preparation of the PVN, CRH neurons were identified by the 
expression of tdTomato fluorescence (A; 10x magnification). (B) A patch-clamped CRH 
neuron at 40x magnification under differential interference contrast (DIC; top) and 
fluorescence (FLU; bottom).  
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2.2 Repeated Restraint Stress Protocol 
RRS consisted of daily 1-hour restraint (13:00–14:00 during the light phase) for 21 
consecutive days. The restrainer was constructed from a ventilated 50 mL plastic tube 
with an adjustable plunger to restrict forward/backward movement (Fig. 2.2).  A hole was 
cut in the lid to allow room for the tail when the lid was closed. In addition, plastic bars 
were added to the bottom of the tube to prevent turning and rolling. Mice in restrainers 
were placed in a large transparent plastic container (dimensions: 45cm length x 35cm 
width x 20cm height). Following the session, mice were returned to their home cage and 
all restrainers were sterilized using a 0.06% dilution of Virox (Diversey Inc.). Control 
mice were kept in their home cage in the animal facility.  
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Figure 2.2 Repeated restraint stress tube 
The restrainer was constructed from a ventilated 50 mL plastic tube with an adjustable 
plunger (plastic stick glued to button) to restrict forward/backward movement. Plastic 
bars were glued to the bottom of the tube to prevent rolling.  
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2.3 Slice Preparation 
Stressed mice were sacrificed on the 22nd day following the 21-day RRS paradigm to 
probe the lasting plasticity of CRH neurons. Mice were deeply anesthetized in a chamber 
saturated with isoflurane and then decapitated. Brains were quickly removed and placed 
in ice-cold slicing solution containing (in mM): 87 NaCl, 2.5 KCl, 0.5 CaCl2, 7 MgCl2, 25 
NaHCO3, 25 D-glucose, 1.25 NaH2PO4 and 75 sucrose (osmolarity 315–320 mOsm) 
saturated with 95% O2/5% CO2. Coronal sections (250 m thick) containing the PVN 
were cut using a vibratome (VT-1200, Leica Biosystems). Slices were trimmed around 
the PVN and transferred to artificial cerebrospinal fluid (aCSF) consisting of (in mM): 
126 NaCl, 2.5 KCl, 26 NaHCO3, 2.5 CaCl2, 1.5 MgCl2, 1.25 NaH2PO4 and 10 D-glucose 
(295–300 mOsm), saturated with 95% O2/5% CO2 and incubated at 35 C for 45 minutes. 
Slices were subsequently maintained at room temperature. Experiments performed in 
low-Ca2+ aCSF and zero-Ca2+ aCSF, were adjusted to (in mM): 0.5 CaCl2, 2.5 MgCl2 and 
0 CaCl2, 4 MgCl2, respectively.  
2.4 Electrophysiology 
Slices were transferred to a recording chamber superfused with aCSF at a flow rate of 
1.5–2.0 mL/min and maintained at 27–30 C. CRH neurons were visualized using a 40 × 
water-immersion lens on an upright microscope equipped with infrared differential 
interference contrast optics (BX 51WI, Olympus) and epifluorescence optics. CRH 
neuron identification was confirmed by the presence of tdTomato fluorescence and their 
characteristic firing pattern in response to depolarizing current steps in current clamp 
(Fig. 2.3; Luther & Tasker, 2000; Wamsteeker Cusulin et al., 2013). Borosilicate glass 
recording pipettes (BF120-69-15, Sutter Instruments) were pulled in a Flaming/Brown 
Micropipette Puller (P-1000, Sutter Instruments) with an open tip resistance between 3–5 
M. Pipettes were filled with an internal solution containing (in mM): 116 K-gluconate, 
8 KCl, 10 HEPES, 2 MgCl2, 4 K2ATP, 0.3 Na3GTP and 10 BAPTA-K4 (285–290 mOsm, 
pH 7.2–7.4). Glutamatergic EPSCs were recorded by holding the CRH neuron soma at -
68 mV in voltage clamp and isolated by adding picrotoxin (100 M) to the aCSF to block 
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GABAA receptors. Access resistance was monitored throughout the recording and cells 
were discarded if the value exceeded 20 M.  
In eEPSC experiments. Afferent CRH inputs were stimulated with a monopolar glass 
electrode (1–3 μm open tip diameter) filled with aCSF and placed in the neuropil along 
the third ventricle ventromedial to the PVN. A paired pulse protocol (0.2 Hz, 50 ms 
apart) was used to investigate EPSC properties.  
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Figure 2.3 Current clamp protocol for the identification of CRH neurons 
(A) From a holding potential of -68 mV, a hyperpolarizing step of -20 pA was applied for 
300 ms, followed by a 700 ms depolarizing pulse that increased by 10 pA increments 
every sweep for a total of 10 sweeps. (B) Representative trace of parvocellular CRH 
neuron firing pattern in response to a depolarizing current step.  
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2.5 Pharmacology 
For list of all reagents used see Table 2.1. Each drug was dissolved into stock solutions 
and stored at -20 C, then diluted to their final concentration in the aCSF on the day of 
the experiment. When DMSO or ethanol was used as a solvent, the final concentration of 
solvent in the aCSF was ≤ 0.1%. All drugs were added to the aCSF and superfused into 
the bath, unless otherwise specified.  
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Reagent Conc. 
(μM) 
Supplier Cat # Action Vehicle 
Picrotoxin 100 Sigma P1675 GABAAR 
antagonist 
DMSO 
DNQX  10 Tocris 189 AMPA/kainate R 
antagonist 
DMSO 
Forskolin  20 Sigma F3917 Adenylyl cyclase 
activator 
Ethanol 
TTX  0.5/1 Alomone 
Labs 
T-550 VG Na+ blocker H2O 
CdCl2  10 Sigma 202908 Ca2+ channel 
antagonist 
H2O 
1,9-Dideoxyforskolin 20 Tocris 5034 Inactive forskolin 
analog 
Ethanol 
Sp-cAMPS  100 Biolog Life 
Science 
C 012-
05 
cAMP analog DMSO 
IBMX  100 Cayman 13347 PDE inhibitor Ethanol 
ZD7288  15/70 Cayman 15228 HCN antagonist DMSO 
U0126  20 Cayman 70970 ERK antagonist DMSO 
ESI 09  10 Tocris 4773 EPAC antagonist DMSO 
KT 5720  5 Tocris 1288 PKA antagonist DMSO 
CsCl  1–2 mM Sigma 289329 non-specific HCN 
antagonist 
H2O 
NiCl2  500 μM 
/1 mM 
Sigma 203866 T-Type Ca2+ 
channel antagonist 
H2O 
Serotonin 
hydrochloride  
50 Tocris 3547 5-HT R activator H2O 
4-Aminopyridine 30 Sigma 275875 Kv channel 
antagonist 
H2O 
Table 2.1 Reagent Information 
List of drugs used in all experiments. Concentrations are listed in μM, unless otherwise 
specified. 
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2.6 Data Collection, Analysis and Statistics 
Whole cell patch clamp recordings were obtained using a Multiclamp 700B amplifier 
(Molecular Devices, California, USA), low pass filtered at 1 kHz and digitized at a 
sampling rate of 10 kHz using Digidata 1440A (Molecular Devices). Data was recorded 
on a PC using pClamp 10.6 (Molecular Devices) and analyzed using MiniAnalysis 
(Synaptosoft, Georgia, USA) and Clampfit (Molecular Devices). Statistical tests were 
performed in GraphPad Prism 7 (GrapPad Software Inc, California, USA) and p < 0.05 
was considered to be statistically significant. Two group comparisons were done using 
paired t-tests, and two-way ANOVA’s were used for multiple group comparisons, 
followed by Sidak’s test or Tukey’s test for post-hoc multiple comparisons. For sEPSC 
analysis baseline data was taken at least 5 mins after breaking through into whole-cell 
mode and a 0.5 or 1 min bin was used for analysis. Unless otherwise specified, drugs 
were applied for 10 minutes and the last 0.5 or 1 min was used for analysis. To achieve 
an accurate measure of the amplitude, individual sEPSCs were visually screened in 
MiniAnalysis, and all overlapping events were removed for the calculation of the average 
amplitude. Events below 5 pA were not included.  
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Chapter 3  
3 Results 
One commonly used approach to estimate the function of synapses is to use patch-clamp 
electrophysiology in acute brain slices and examine spontaneous (or miniature) synaptic 
transmission, for example EPSCs mediated by ionotropic glutamate receptors. It is 
generally accepted that the frequency of EPSCs reflects the combination of the following 
two synaptic properties terminating onto a given postsynaptic neuron: 1) the number of 
synapses (N) and 2) the (average) release probability of the of synapses (Pr). On the other 
hand, the average amplitude reflects the postsynaptic sensitivity to release of a single 
synaptic vesicle, typically postsynaptic receptor sensitivity to neurotransmitter (Q). 
Accordingly, in order to probe synaptic plasticity resulting from behavioral manipulation, 
the frequency and/or amplitude of sEPSCs recorded from one population of neurons are 
compared between two conditions, for example under control condition versus after stress 
exposure.  
However, most of the studies using this approach only examine the “baseline” synaptic 
activity in brain slices. This may not fully capture the properties of the synapses, as 
synapses are likely to become more active (e.g., fire at high frequency) as a part of 
physiologically relevant circuit activities. Therefore, for my MSc thesis, we first aimed to 
develop an experimental strategy to study sEPSCs under stress-relevant states in brain 
slices. One key intracellular signaling molecule that stimulates synaptic transmission is 
3’,5’-cyclic adenosine monophosphate (cAMP), and cAMP mediates downstream 
signaling of neuromodulators (e.g., 5HT receptor 4, 6 and 7, β-adrenergic receptors and 
dopamine receptor D1) that drive stress-relevant neuronal activities. Thus, we used 
forskolin, an adenylyl cyclase activator and recorded glutamatergic sEPSCs in the 
presence of picrotoxin (GABAA receptor antagonist).  
3.1 Forskolin drives glutamatergic synaptic transmission to 
CRH neurons 
As shown in Figure 3.1, 10 minutes of forskolin application (20 μM) robustly increased 
the frequency of sEPSCs (Fig. 3.1 A, B; mean frequency: BL 9.22 ± 1.18 Hz vs. FSK 
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29.45 ± 3.01 Hz; paired t test: p < 0.0001, n = 19). Forskolin also caused a moderate 
increase in the mean amplitude of sEPSCs (Fig. 3.1 C; mean amplitude: BL 25.9 ± 1.16 
pA vs. FSK 29.10 ± 1.17 pA, paired t test: p = 0.0022, n = 19) and a slight shift of the 
amplitude distribution towards higher values (Fig. 3.1 D). To further characterize 
forskolin’s effect on CRH neurons, we investigated forskolin-induced frequency increase 
in Ca2+-free aCSF and in the presence of TTX to block Na2+-dependent action potentials. 
Forskolin’s effect was not changed when normal aCSF (2.5 mM Ca2+) was replaced by 
Ca2+-free aCSF (Fig. 3.1 E; frequency after forskolin: normal aCSF 29.45 ± 3.01 Hz (n = 
19) vs. 0 M Ca2+ 32.17 ± 2.62 Hz (n = 7); two-way ANOVA: main effect of aCSF 
condition: F (1, 24) = 0.4894, p = 0.4909). The frequency increase was decreased when 
action potentials were blocked by the sodium (Na+) channel antagonist, TTX (frequency: 
sEPSC 29.45 ± 3.01 Hz (n = 19) vs. mEPSC 19.22 ± 9.57 Hz (n = 10); two-way 
ANOVA: main effect of aCSF condition: F (1, 27) = 6.111, p = 0.0200, interaction: : F 
(1, 27) = 2.19, p = 0.1505; Sidak’s post-hoc test: FSK-sEPSC vs. FSK-mEPSC, p = 
0.0113); however, mEPSC frequency was still increased by forskolin (two-way ANOVA: 
main effect of forskolin: F (1, 27) = 88.65, p < 0.0001), suggesting that forskolin 
increases both action potential-dependent and -independent EPSCs. To rule out the 
possibility that forskolin acts by recruiting a new category of receptors, 6,7-
Dinitroquinoxaline-2,3-dione (DNQX; an AMPA and kainate receptor antagonist) was 
applied after forskolin. Bath application of 10 μM DNQX abolished all synaptic activity 
(Fig. 3.1 F), confirming that forskolin drives glutamatergic AMPA/kainate-mediated 
sEPSCs.  
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Figure 3.1 Forskolin increases glutamatergic synaptic activity 
 (A) Representative traces of sEPSC activity from before (grey) and 10 minutes after 20 
μM forskolin application (orange) showing an increase in the frequency of sEPSCs. (B) 
sEPSC frequency at baseline (BL; grey) and after 10 minutes of forskolin application 
(FSK; orange; p < 0.0001). (C) Mean sEPSC amplitude (1-min bin) showed a slight 
increase from baseline (BL; grey) to after 10 minutes of 20 μM forskolin application 
(FSK; orange; p < 0.0022). (D) Mean amplitude distribution represented as fraction of 
total events over 1 min bin for baseline (BL; grey) and after 10 minutes of 20 μM 
forskolin application (FSK; orange, n = 19). Dotted line represents ± S.E.M. (E) 
Forskolin-induced frequency increase was maintained in the absence of Ca2+ in the aCSF 
(normal Ca2+ (blue) vs. 0 M Ca2+ (teal) at FSK: p = 0.4909). (F) Blocking AP-dependent 
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events (grey; 1 μM TTX) decreased the forskolin-induced frequency increase (sEPSC vs. 
mEPSC at FSK: p = 0.0113); however, forskolin still increased mEPSCs (BL-mEPSC vs. 
FSK-mEPSC: p < 0.0001). Error bars represent ± S.E.M. (G) Representative trace 
showing CRH neuron sEPSC activity in the presence of the GABAA receptor antagonist, 
picrotoxin (100 μM; grey), was increased by forskolin (20 μM, orange), but all activity 
was abolished by application of the AMPA/kainate receptor antagonist, DNQX (10 μM; 
blue), confirming that forskolin drives glutamatergic synaptic activity. Each block 
represents 3 mins of recording.  
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3.2 RRS potentiates forskolin-induced frequency increase 
in CRH neurons 
After establishing forskolin as an efficient means to stimulate glutamatergic sEPSC 
activity in PVN-CRH neurons, we tested whether habituation to chronic stress alters the 
baseline and/or the capacity for forskolin to drive synaptic transmission (Fig. 3.2 A). The 
baseline frequency was not statistically different between naïve and RRS (Sidak’s post-
hoc test: p = 0.1523 for BL-naïve vs. BL-RRS). In contrast, the frequency increase was 
greater in RRS mice than naïve mice (Fig. 3.2 B, D; frequency at FSK: naïve 29.45 ± 
3.01 Hz (n = 19) vs. RRS 48.34 ± 4.12 Hz (n = 16); two-way ANOVA: interaction: F (1, 
33) = 10.77, p = 0.0024; Sidak’s post-hoc test: p <0.0001 for FSK-naïve vs. FSK-RRS), 
which suggests that the stress-induced changes are related to forskolin’s mechanism of 
action. Forskolin’s increase of the amplitude (Fig. 3.2 C, E; two-way ANOVA; main 
effect of FSK: F (1, 33) = 16.56, p = 0.0003) was not altered by stress (main effect of 
stress: p = 0.7696; interaction:  p = 0.3797). To further examine the stress-induced 
changes in glutamatergic synaptic activity, a separate experiment was performed in which 
the K+ channel antagonist, 4-aminopyridine (4-AP), was used to stimulate synaptic 
activity rather than forskolin. 4-AP blocks voltage-dependent K+ channels (Kv 1.1, 1.2, 
1.3, 3.1; Coetzee et al., 1999), and causes a large increase in the frequency of sEPSCs. In 
contrast to forskolin, 4-AP-induced frequency increase was not modified by stress (two-
way ANOVA; main effect of FSK: F (1, 16) = 38.07, p < 0.0001, main effect of stress: p 
= 0.6069, interaction: p = 0.3159, naïve: n = 9, RRS: n = 9), which further supports the 
idea that stress is specifically changing the way forskolin drives synaptic activity. This 
finding suggests that RRS is not causing an overall increase in the number of synapses, 
but rather is altering forskolin’s mechanism of action. 
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Figure 3.2 RRS potentiates forskolin-induced sEPSC frequency increase 
CRH neurons from RRS animals show a greater increase in sEPSC frequency after 
forskolin application. (A) Representative traces showing a CRH neuron from a naïve 
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animal (top) and an RRS animal (bottom) at baseline (BL; grey) and after 10 mins of 
forskolin application (FSK; blue and red for naïve and RRS, respectively). (B) RRS (red) 
potentiated the forskolin-induced sEPSC frequency increase in CRH neurons compared 
to naïve (blue; naïve vs. RRS at FSK: p < 0.0001). Baseline frequency was higher but not 
significantly different after RRS (naïve vs. RRS at BL: p = 0.1523). (C) Mean sEPSC 
amplitude over 1-minute bin at baseline (BL) and after 10 minutes of forskolin (FSK) in 
naïve (blue) and RRS (red) mice. Forskolin slightly increased the amplitude in naïve and 
RRS CRH neurons (p = 0.0003), but there was no difference between the two groups (p = 
0.7696). (D) Individual cell data for sEPSC frequency for naïve and RRS at BL (grey) 
and after 10 mins FSK (blue and red for naïve and RRS, respectively). (E) Individual cell 
data for mean sEPSC amplitude for naïve and RRS at BL (grey) and after 10 mins FSK 
(blue and red for naïve and RRS, respectively). (F) Probing sEPSC frequency with 4AP 
(30 μM) did not reveal a difference between naïve and RRS (main effect of stress: p = 
0.6069). Error bars represent ± S.E.M. 
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3.3 Forskolin’s effects are dependent on adenylyl cyclase 
and mimicked by cAMP 
To further investigate how stress changes forskolin’s effect, we first had to determine 
forskolin’s mechanism of action in CRH neurons from naïve mice. Forskolin is widely 
known to stimulate PKA activity through an adenylyl cyclase-cAMP mechanism; 
however, there are other downstream mechanisms reported in the literature (Fig. 3.3 A; 
Emery & Eiden, 2012; Emery, Liu, Xu, Eiden, & Eiden, 2015; Huang & Hsu, 2005). To 
pinpoint the mechanism through which forskolin increases sEPSC frequency in CRH 
neurons, we targeted each pathway individually using pharmacology. Forskolin is a direct 
activator of adenylyl cyclase, which catalyses the conversion of ATP into cAMP. 
Therefore, if forskolin acts through the adenylyl cyclase-cAMP mechanism, cAMP alone 
should mimic its effect. In line with this prediction, the drug Sp-cAMPS 
triethylammonium salt (Sp-cAMP), a cAMP analog, increased the frequency of sEPSCs 
(Fig. 3.3 C; BL 5.73 ± 1.37 Hz vs. Sp-cAMP 12.13 ± 2.37 Hz, paired t test: p = 0.0462, n 
= 4). Endogenously, cAMP is broken down by phosphodiesterase (PDE), and 
consequently, inhibiting PDE activity should increase endogenous levels of intracellular 
cAMP. Indeed, we found that bath application of 1-Methyl-3-Isobutylxanthine (IBMX), a 
PDE inhibitor, caused a large increase in the sEPSC frequency (Fig. 3.3 D; BL 9.86 ± 
1.97 Hz vs. IBMX 22.77 ± 2.41 Hz, paired t test, p = 0.0033, n = 4). Taken together, 
these data suggest that cAMP increases the frequency of sEPSCs in CRH neurons, which 
indicates that forskolin is likely acting through adenylyl cyclase and cAMP to have its 
effect on the frequency. While our data strongly supports an adenylyl cyclase-dependent 
mechanism for forskolin’s effect, forskolin has been found to have nonspecific, adenylyl 
cyclase-independent effects (Laurenza, Sutkowski, & Seamon, 1989), such as inhibition 
of glucose transport in blood cells (Lavis, Lee, & Shenolikar, 1987), enhancement of 
nicotinic receptor desensitization in muscle fibers (Middleton, Rubin, & Schuetze, 1988), 
and modulation of voltage-gated K+ channels in neurons (Coombs & Thompson, 1987) 
and T cells (Krause, Lee, & Deutsch, 1988). To rule out non-specific effects of forskolin, 
we applied 1,9-dideoxyforskolin (DDFSK), an inactive forskolin analog, which mimics 
the adenylyl cyclase-independent effects of forskolin. Bath application of DDFSK (20 
μM) did not increase sEPSC frequency, but actually caused a slight decrease (Fig. 3.3 B; 
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BL 6.22 ± 0.71 Hz vs. DDFSK 4.53 ± 0.55 Hz, paired t test: p = 0.0123, n = 9), 
suggesting the increase in frequency seen with forskolin is mediated through an adenylyl 
cyclase-dependent mechanism. 
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Figure 3.3 Forskolin-induced frequency increase is dependent on adenylyl cyclase 
and mimicked by cAMP 
(A) Flow chart showing downstream targets of forskolin. Forskolin binds directly to 
adenylyl cyclase but can have nonspecific effects. Adenylyl cyclase increases cAMP, 
which can activate downstream pathways including: protein kinase A (PKA), exchange 
factor regulated by cAMP (EPAC), extracellular regulated kinase (ERK) and 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. (B) The inactive 
forskolin-analog DDFSK (light purple; 20 μM), that mimics the adenylyl cyclase-
independent effects of forskolin, did not reproduce the forskolin-induced frequency 
increase. (C) Sp-cAMP (pink; 100 μM), a cAMP analog, increased the frequency of CRH 
neuron sEPSCs (p = 0.046). (D) Blocking phosphodiesterase (PDE)-dependent 
43 
 
degradation of cAMP (and therefore increasing cAMP) with IBMX (dark purple; 100 
μM) increased the sEPSC frequency (p = 0.003).  
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3.4 Blocking HCN channels attenuates forskolin-induced 
frequency increase 
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are dually regulated 
by membrane potential and by cAMP binding (He, Chen, Li, & Hu, 2014). The opening 
of HCN channels is triggered by hyperpolarization of the cell membrane and causes a 
depolarizing inward current, primarily composed of Na+. When cAMP is bound, HCN 
channels (which normally open at membrane potentials more hyperpolarized than -50 
mV) can open at a more depolarized membrane potential, which increases the proportion 
of channels that are open at rest. Therefore, it is possible that the forskolin-induced 
increase in cAMP is activating HCN channels, causing greater depolarization in 
presynaptic terminals, and facilitating the release of synaptic vesicles. We next tested the 
potential role of HCN channels by applying forskolin in the presence of the HCN channel 
antagonist ZD7288 (ZD; Fig. 3.4 A). Bath application of ZD7288, at both 15 and 70 μM, 
attenuated the sEPSC frequency increase by forskolin (Fig. 3.4 B; frequency: FSK 29.45 
± 3.01 Hz (n = 19) vs. FSK+15 μM ZD 15.39 ± 2.07 Hz (n = 14) vs. FSK+70 μM ZD 
16.19 ± 3.25 Hz (n = 12); two-way ANOVA: interaction: F (2, 41) = 6.54, p = 0.0034; 
Tukey’s post-hoc test: FSK vs. FSK+15μM ZD: p < 0.0001, FSK vs. FSK+70μM ZD: p = 
0.0002, FSK+15μM ZD vs. FSK+70μM ZD: p = 0.9937). ZD7288 application alone at 
baseline did not change the frequency or amplitude (Tukey’s post-hoc test: BL vs. 
BL+15μM ZD: p = 0.4106, BL vs. BL+70μM ZD: p = 0.5617, BL+15μM ZD vs. 
BL+70μM ZD: p = 0.9971). To verify that ZD7288 effectively blocks HCN channels in 
our preparation, we examined the characteristic HCN channel sag that is produced after 
membrane hyperpolarization. As described earlier, hyperpolarization opens HCN 
channels, which in turn generates an opposing depolarizing drive, and as a consequence 
causes a sag in membrane hyperpolarization. We used a 30 pA hyperpolarizing step pulse 
in current clamp for 5 seconds from a membrane potential of -40 mV to ensure HCN 
channels were inactivated. CRH neurons have a small but readily detectable HCN sag 
component (Fig. 3.4 C; black arrow): this sag was completely eliminated by bath 
application of 15 μM ZD7288. As illustrated, blocking HCN channels prevented the 
forskolin-induced frequency increase, suggesting forskolin may have its effect through 
HCN channels.  
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Figure 3.4 The HCN channel antagonist, ZD7288, attenuated the forskolin-induced 
sEPSC frequency increase  
(A) Representative traces showing that 70 μM ZD7288 application (grey) before 
forskolin prevented the sEPSC frequency increase (green). (B) Application of forskolin in 
the presence of 15 μM (yellow) and 70 μM (green) ZD7288 blocked the forskolin-
induced sEPSC frequency increase (FSK vs. FSK+15μM ZD: p = 0.0032, FSK vs. 
FSK+70μM ZD: p = 0.0083). (C) Current clamp recordings from a representative CRH 
neuron showing that the small HCN sag in CRH neurons (arrow) at baseline (black) was 
blocked after bath application of 15 μM ZD (yellow). Current clamp protocol to reveal 
the sag is shown at bottom; 30 pA hyperpolarizing step for 5 seconds from a holding 
potential of -40 mV in the presence of 1 μM TTX. Error bars represent ± S.E.M.  
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3.5 Forskolin’s mechanism is independent of PKA and 
EPAC pathways but may involve the ERK pathway 
While HCN channels clearly contribute to forskolin’s effect, the increase in frequency 
was not completely abolished by blocking HCN channels, pointing to roles for additional 
pathways. Next, we investigated three other pathways downstream of cAMP; 
extracellular regulated kinase (ERK), exchange factor regulated by cAMP (EPAC) and 
protein kinase A (PKA). Bath application of the ERK antagonist U0126 significantly 
attenuated forskolin-induced frequency increase (Fig. 3.5 A; frequency: FSK 29.45 ± 
3.01 Hz (n = 19) vs. FSK+U0126 12.88 ± 3.51 Hz (n = 6); two-way ANOVA: 
interaction: F (1, 23) 5.739, p = 0.025; Sidak’s post-hoc test: BL vs. BL+U0126: p = 
0.3190; FSK vs. FSK+U0126: p = 0.0008), suggesting that forskolin increases frequency 
through the ERK pathway, in addition to HCN channels. In contrast, application of PKA 
and EPAC antagonists (KT 5720 and ESI 09, respectively) did not weaken forskolin’s 
effect (Fig. 3.5 B; frequency: FSK 29.45 ± 3.01 Hz (n = 19) vs. FSK+KT/ESI 23.97 ± 
3.25 Hz (n = 4); two-way ANOVA: main effect of drug: p = 0.3662, interaction p = 
0.6056), suggesting it is independent of these pathways. 
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Figure 3.5 Forskolin’s mechanism is independent of PKA and EPAC but not ERK 
pathways 
(A) U0126, an ERK inhibitor (burgundy) attenuated the frequency increase (FSK vs. 
FSK+U0126: p = 0.0008) compared to forskolin alone (blue). (B) Inhibiting PKA (KT 
5720) and EPAC (ESI 09; purple) did not inhibit the increase in frequency compared to 
forskolin alone (FSK vs. FSK+KT/ESI: p = 0.3662). Error bars represent ± S.E.M. 
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3.6 Forskolin acts through presynaptic HCN channels  
The classic interpretation based on quantal theory of neurotransmitter release (Del 
Castillo & Katz, 1954; Redman, 1990; Stevens, 1993) indicates that a change in 
frequency is due to a change presynaptic release. Therefore, forskolin likely increases 
frequency through a presynaptic mechanism. To further investigate whether forskolin’s 
mechanism is presynaptic, we recorded evoked EPSCs (eEPSCs) by stimulating the 
afferent inputs to CRH neurons using an extracellular electrode placed in the neuropil 
ventromedial to the postsynaptic neurons. Forskolin increased the eEPSC amplitude (Fig. 
3.6 A–C; 135.4% of BL ± 12.36 %; paired t test: p = 0.0035, n = 12). In line with the 
hypothesis that forskolin’s mechanism is presynaptic, this increase in eEPSC amplitude 
was accompanied by a change in the coefficient of variation (1/CV2), which indicates 
changes in Pr and N. Specifically, forskolin (Fig. 3.6 D, E; blue) increased 1/CV2 (BL vs. 
FSK: p = 0.0236, n = 12), suggesting forskolin changes the probability of presynaptic 
release. PPR was not significantly different (BL vs. FSK: p = 0.3952).  
Our working hypothesis is that HCN channels mediate forskolin’s action on EPSCs. In 
line with this idea, the forskolin-induced increase of eEPSC amplitude was completely 
blocked by both 15 and 70 μM ZD7288 (Fig. 3.6 C; FSK 135.4% of BL ± 12.36 % (n = 
12) vs. FSK+ZD 79.0% of BL ± 0.08 % (n = 15); two-way ANOVA: interaction: F (1, 
25) = 14.03, p = 0.0009; Sidak’s post-hoc test: BL vs. BL+ZD: p = 0.9645, FSK vs. 
FSK+ZD: p = 0.0067). Moreover, there was also a trend for ZD7288 to block the 
forskolin-induced increase in 1/CV2 (Fig. 3.6 D; two-way ANOVA: interaction: F (1, 25) 
= 4.11, p = 0.0534; Sidak’s post-hoc test: BL vs. BL+ZD: p = 0.9930, FSK vs. FSK+ZD: 
p = 0.0134). As this data was not normally distributed (Shapiro-Wilk normality test: BL: 
W = 0.6259, p = 0.0002; BL+ZD: W = 0.6426, p = 0.0001), 1/CV2 values were log-
transformed. These data collectively suggest that forskolin acts through a presynaptic 
mechanism and ZD7288 is able to block this mechanism.  
If presynaptic HCN channels mediate forskolin’s effect, blocking HCN channels 
specifically on the postsynaptic side should not change the effects of forskolin. We tested 
this by applying the drug directly into the postsynaptic cell through the patch pipette. 
ZD7288 is not cell permeable so when it is added to the intracellular solution and whole 
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cell mode is established, ZD7288 will block only the postsynaptic, and not the 
presynaptic, HCN channels. In contrast to bath application, ZD7288 in the pipette (ZDp) 
at both 15 and 70 μM did not block forskolin-induced increase of the sEPSC frequency 
(Fig. 3.6 F; two-way ANOVA: main effect of drug condition: F (3, 49) = 3.607, p = 
0.0197; interaction: F (3, 49) = 3.85, p = 0.0150; Tukey’s post-hoc test: FSK vs. 
FSK+15μM ZDp: p = 0.9971, FSK vs. FSK+70μM ZDp: p > 0.9999, FSK+15μM ZDbath 
vs. FSK+15μM ZDp: p = 0.0036). As postsynaptic blockade of HCN channels was not 
sufficient to block forskolin’s frequency increase, the HCN channels involved in 
forskolin’s effect are likely presynaptic. This suggests a possible mechanism through 
which forskolin increases sEPSC frequency: forskolin increases cAMP, which activates 
presynaptic HCN channels and causes depolarization of the presynaptic terminals leading 
to an increase in the release probability.  
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Figure 3.6 Forskolin and ZD7288 act presynaptically 
(A) Representative cell showing average paired-pulse eEPSC amplitude response at 
baseline (black) was increased after 10 minutes of forskolin application (orange). (B) 
eEPSC amplitude time-course expressed as a percent of the baseline (normalized to first 
5 mins) amplitude. Forskolin application at time 0 (orange bar) increased eEPSC 
amplitude. (C) Average eEPSC amplitude increased after forskolin (blue), but this 
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increase was blocked by ZD7288 (yellow; FSK vs. FSK+ZD: p = 0.0067). (D) 1/CV2 
increased after forskolin (blue), but this was blocked when ZD7288 (yellow) was present 
(FSK vs. FSK+ZD: p = 0.0134). (E) PPR was not significantly different after forskolin 
(blue) or in the presence of ZD7288 (yellow). (F) Forskolin-induced sEPSC frequency 
was not blocked when ZD7288 was applied through the pipette at both 15 μM (dark 
purple) and 70 μM (light purple), rather than bath applied (FSK+ZDbath vs. FSK+15μM 
ZDp: p = 0.0036, FSK+ZDbath vs. FSK+70μM ZDp: p = 0.0079). Error bars represent ± 
S.E.M. 
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3.7 Blocking HCN channels eliminates the difference 
between RRS and naïve animals 
The above data revealed that presynaptic HCN channels at least partly mediate the effects 
of forskolin on glutamate synapses in CRH neurons. Earlier, we also found that RRS 
potentiates forskolin’s ability to drive synaptic transmission. Interestingly, chronic stress 
has been found to upregulate HCN-mediated currents in the hippocampus (Kim, Brager, 
& Johnston, 2017) and prefrontal cortex (Arnsten, 2011). In contrast, HCN-mediated 
currents in the ventral tegmental area are decreased after chronic stress, which led to 
increased anxiety and depressive behaviour (Zhong et al., 2018). Taken together, we 
hypothesized that this stress-induced potentiation of synaptic transmission involves 
changes in the presynaptic HCN channel mechanisms. If so, the blockade of HCN 
channels should abolish stress-induced augmentation. In line with this prediction, we 
found that application of ZD7288 prior to forskolin abolished the difference between 
naïve and stressed mice. As seen in Figure 3.7 A, when ZD7288 was present, forskolin’s 
effect was the same in naïve (yellow) and RRS (red; frequency: FSK+ZD-naïve 16.19 ± 
3.25 Hz (n = 12) vs. FSK+ZD-RRS 14.41 ± 2.41 Hz (n = 6); two-way ANOVA: main 
effect of stress: F (1, 16) = 0.05, p = 0.8179; main effect of forskolin: F (1, 16) = 24.42, p 
= 0.0001; interaction: F (1, 16) = 0.2987, p < 0.5922). When HCN channels are blocked, 
the stress-induced difference was eliminated, suggesting the initial difference may be due 
to a change in HCN channel function after stress.  
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Figure 3.7 Blocking HCN channels eliminates the difference between naïve and RRS 
(A) In CRH neurons from RRS mice, the stress-induced potentiation of forskolin’s effect 
was eliminated by ZD7288 (p = 0.8176). (B) Graph from Figure 3.2 for comparison, 
showing the stress-induced difference in forskolin-induced increase of sEPSC frequency 
without ZD7288. Error bars represent ± S.E.M. 
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3.8 Cesium and nickel do not block forskolin’s effect 
ZD7288 is generally considered a specific antagonist for HCN channels, and there are no 
other inhibitors for HCN channels known to be more specific than ZD7288. However, 
there are several studies reporting non-specific effects (Chen, 2004; Chevaleyre & 
Castillo, 2002; Sánchez-Alonso, Halliwell, & Colino, 2008; Wu et al., 2012). As an 
approach to validate the specificity of ZD7288, we used cesium (Cs+), which is known to 
block HCN channels in addition to other ion channels including various K+ channels 
(Adelman & French, 1978). Our prediction was that if ZD7288 reverses the effects of 
forskolin by targeting HCN channels, Cs+ would produce similar effects by inhibiting the 
same target. Unfortunately, Cs+ had non-specific actions that made it impossible to 
analyze the effect of forskolin in our preparation. Specifically, Cs+ caused an increase in 
the sEPSC frequency independent of forskolin, and forskolin-induced frequency increase 
was not different in the presence of Cs+ (Fig. 3.8 A; frequency: FSK 29.45 ± 3.01 Hz (n = 
19) vs. FSK+Cs+ 36.09 ± 5.42 Hz (n = 6), two-way ANOVA: main effect of condition: p 
= 0.1335, interaction: p = 0.8560). Cs+ potently inhibits multiple K+ channels and, as a 
consequence, increases the frequency of sEPSCs, which may have masked its antagonist 
actions on HCN channels. Thus, the results from the Cs+ experiment are inconclusive.  
As a complementary approach, we also examined potential (non-specific) targets of 
ZD7288. One possible nonspecific effect of ZD7288 is the blockade of low-threshold (T-
type) Ca2+ channels (Sánchez-Alonso et al., 2008), which are expressed in the PVN. To 
test this possibility, we used Nickel (Ni2+), a T-type Ca2+ channel antagonist, and applied 
forskolin. Forskolin’s effect was not altered by Ni2+ application (Fig 3.8 B; frequency: 
FSK 29.45 ± 3.01 Hz (n = 19) vs. FSK+Ni2+ 24.85 ± 7.22 (n = 6); two-way ANOVA: 
interaction: p = 0.5693, main effect of Ni2+ condition: p = 0.8749). This result suggests 
that ZD7288 was not acting on T-type Ca2+ channels to block the frequency increase. 
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Figure 3.8 Cesium and nickel do not block sEPSC frequency increase 
(A) Cesium (pink), the non-specific HCN antagonist did not block the frequency increase 
by forskolin (p = 0.1335). (B) Ni2+ (teal), a T-type Ca2+ channel antagonist, did not block 
forskolin-induced frequency increase (FSK vs. FSK+Ni2+: p = 0.5992). 
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3.9 Serotonin mimics forskolin-induced frequency increase 
Lastly, as forskolin is not endogenous, we were interested in identifying whether this 
plasticity has physiological relevance with neuromodulators that act similarly to 
forskolin. Forskolin activates the cAMP pathway, meaning it will likely mimic 
neuromodulators that act on Gαs coupled G protein-coupled receptors (GPCRs). As 
serotonin is known to innervate CRH neurons (Sawchenko, Swanson, Steinbusch, & 
Verhofstad, 1983), we tested whether 5-HT could reproduce forskolin’s effects. We 
found that bath application of 5-HT robustly increased sEPSC frequency in CRH neurons 
(Fig. 3.9, A; BL 6.51 ± 1.70 Hz vs. 5-HT 19.04 ± 3.34 Hz, paired t test: p = 0.0269, n = 
4), suggesting serotonin has the same effect as forskolin on CRH neurons. Therefore, as 
forskolin causes a greater increase after stress, it is possible that serotonin inputs may 
have a greater capacity to increase glutamatergic synaptic transmission after RRS.  
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Figure 3.9 Serotonin increases sEPSC frequency in CRH neurons 
(A) Bath application of serotonin (dark blue) increased the frequency of sEPSCs (p = 
0.040). 
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Chapter 4  
4 Discussion 
This study examined the plasticity of afferent glutamatergic inputs to CRH neurons in a 
mouse model of RRS, in which mice habituate to the repeated stressor (restraint) while 
maintaining a normal (or sensitized) response to a novel stressor. Our major finding is 
that RRS potentiates glutamatergic synapses to CRH neurons, which manifested as an 
increased response to cAMP stimulation by forskolin. Importantly, this stress-induced 
synaptic potentiation, which became apparent when the synapses were active/stimulated, 
was specific to the type of synaptic stimulation: forskolin (that elevates intracellular 
cAMP), but not 4-AP (that increases action potential firing), revealed the increased 
capacity for activity. This finding suggests that RRS animals may have a greater response 
to neurotransmitters that activate cAMP pathways in the PVN. When we investigated this 
mechanism further, we found that it was dependent on presynaptic HCN channels and 
may have some involvement of the ERK pathway. Overall, this finding highlights a 
possible mechanism which could support the ability of the HPA axis to mount a normal 
(or sensitized) response to a novel stressor despite being habituated to chronic stress. Our 
group has data showing that RRS decreases the intrinsic excitability of CRH neurons 
(i.e., a decreased input-output relationship), and the present study suggests that 
glutamatergic synapses onto CRH neurons are potentiated in the same RRS model. This 
increased capacity for synaptic activity could overcome the decreased excitability by 
increasing the synaptic drive to CRH neurons, suggesting it could serve as a mechanism 
for sensitization to novel stress.  
4.1 Forskolin as a means to drive synaptic activity  
Forskolin causes a robust increase in glutamatergic synaptic activity in CRH neurons 
resulting in an increase in the frequency of sEPSCs. We used forskolin, as a tool to study 
the properties of glutamatergic synapses to CRH neurons under a “high activity” state 
which would recapitulate stress-relevant physiological activity: neuromodulators that are 
known to stimulate CRH neurons (noradrenaline, serotonin, dopamine) elevate 
intracellular cAMP levels.  
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Forskolin is a diterpene isolated from the Indian plant Coleus forskohlii that acts directly 
on adenylyl cyclase to increase the levels of cAMP within cells (Seamon & Daly, 1981; 
Seamon, Padgett, & Daly, 1981). The membrane bound enzyme, adenylyl cyclase, 
catalyses the conversion of adenosine triphosphate (ATP) into 3’,5’-cyclic AMP (cAMP) 
and pyrophosphate. Forskolin binds to all classes of mammalian adenylyl cyclase, with 
the exception of IX, at a binding site that seems to be specific for forskolin, as no 
endogenous molecules have been found to have the same mechanism (Hurley, 1999). 
Hurley (1999) noted that the forskolin binding site is highly conserved across all classes 
of adenylyl cyclase, despite there being no endogenous molecule that binds at the same 
location. He suggested that this paradox may hint at the existence of an endogenous 
“forskolin-like” small molecule that is able to activate adenylyl cyclase. As no such 
molecule has been identified, forskolin has mainly been used as a proxy to study the 
effects of GPCR pathways that activate adenylyl cyclase by the binding to the GαS 
protein subunit. Forskolin has also been shown to have adenylyl cyclase-independent 
binding to glucose transporters, voltage-gated K+ channels, ligand-gated ion channels and 
P glycoproteins (Sunahara, Dessauer, & Gilman, 1996). Each of these effects are 
mimicked by the inactive forskolin analog, DDFSK, which does not bind to adenylyl 
cyclase (Laurenza et al., 1989). As DDFSK did not mimic the forskolin-induced effect on 
sEPSC frequency in the present experiment, we concluded that the increase in frequency 
by forskolin in CRH neurons is dependent on adenylyl cyclase. In line with this 
conclusion we found that increasing cAMP, either by a cAMP analog or inhibition of 
phosphodiesterases (PDEs), which break down cAMP, also increased sEPSC frequency 
in CRH neurons. These data support the conclusion that forskolin is probing adenylyl 
cyclase and its role in increasing intracellular cAMP and is therefore, an effective tool to 
test the effect of GPCRs coupled to cAMP-stimulating GαS. 
We also found that the stress-induced difference was specific to forskolin’s stimulation of 
synaptic activity, rather than an overall increase in activity. As mentioned above, we used 
a second approach to drive glutamatergic afferents, namely, stimulation of action 
potential firing by blocking voltage-gated K+ channels with 4-AP. We have previously 
shown that 4-AP increases sEPSC frequency in naïve mice (Salter et al., 2018); however, 
in contrast to forskolin, there was no difference in 4-AP-induced frequency increase 
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between RRS and naïve mice. This finding indicated that the stress-induced change we 
observed was specific to the pathway forskolin was acting on and led us to investigate 
forskolin’s mechanism further.  
Interestingly, in vitro studies have shown that forskolin drives the release of CRH in a 
cAMP-dependent manner (Hadley et al., 1996; Kumari, Cover, Poyser, & Buckingham, 
1997). This was primarily attributed to forskolin-induced increases in CRH gene 
transcription; however, our results suggest that there are potent acute effects of forskolin 
on the excitatory synaptic inputs to CRH neurons, which could drive HPA axis activation 
independent of the slower transcription pathways. This prompts an interesting study, 
which suggests that the glutamatergic synaptic input to CRH neurons can actually trigger 
downstream molecular machinery that ultimately results in the transcription of CRH 
(Korosi et al., 2010). These findings highlight the importance of studying the acute 
effects of driving cAMP on synaptic activity.  
4.2 HCN channels  
HCN channels are a unique class of ion channels that are activated by membrane 
hyperpolarization and regulated by cyclic nucleotides (cAMP, cGMP). HCN channels 
open at membrane potentials more negative to -50 mV, and cAMP facilitates their 
activation by increasing the membrane potential at which they can open (He et al., 2014). 
The opening of HCN channels causes an inward cationic current (Ih) that counteracts the 
initial hyperpolarization. HCN channels are permeable to Na+, and to a lesser extent, K+ 
and Ca2+; however, as they open at hyperpolarized membrane potentials the Ih is 
primarily composed of Na+. There are four subtypes of HCN channels (HCN1–4), and 
each exhibit different activation kinetics and cAMP-sensitivity, with HCN2 and HCN4 
being the most sensitive and HCN1 and HCN3 under weaker regulation (He et al., 2014). 
HCN channels play an important role in regulating membrane potential and consequently 
contribute to neuronal oscillations, dendritic integration and synaptic transmission in 
various brain regions. The functional consequences of HCN channel activation depend 
entirely on where in the brain and in the neuron, the channels are expressed. For example, 
at the synaptic level, activation of HCN channels in presynaptic terminals has been found 
to increase the amplitude of sEPSCs by increasing the Na+ gradient between the cytosol 
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and synaptic vesicles, which is responsible for loading glutamate into synaptic vesicles 
(Huang & Trussell, 2014). Alternatively, HCN channels expressed in distal dendrites can 
decrease the membrane resistance and dampen dendritic integration, thereby decreasing 
sEPSC amplitude (He et al., 2014). It has also been found that HCN channels can interact 
with other ion channels to modify synaptic transmission. Given the diversity of effects on 
neuronal activity, the modification and plasticity of HCN channels can have major 
implications in diseases such as epilepsy, neuropathic pain, Parkinson’s disease, and 
depression (He et al., 2014; Ku & Han, 2017; Lewis & Chetkovich, 2011). 
4.3 Forskolin acts through presynaptic HCN channels 
Here, we have found that presynaptic HCN channels are involved in forskolin-induced 
sEPSC frequency increase in CRH neurons. Three lines of evidence support this 
conclusion: 1) Forskolin increased the frequency and ZD7288 blocked the frequency 
increase. The classic interpretation based on quantal theory of neurotransmitter release 
(Del Castillo & Katz, 1954; Redman, 1990; Stevens, 1993) indicates that a change in 
frequency is due to a change in presynaptic neurotransmitter release probability. 2) 
Forskolin increased eEPSC amplitude which was paralleled by changes in synaptic 
parameters indicative of presynaptic changes (i.e., an increase in 1/CV2). Similar to 
sEPSC changes, ZD7288 blocked the forskolin-induced amplitude increase as well as the 
accompanying changes in 1/CV2. 3) ZD7288 application through the postsynaptic pipette 
did not block forskolin’s effect. ZD7288 blocks HCN channels through the interaction 
with residues in the channel pore (Shin, Rothberg, & Yellen, 2001), and as ZD7288 does 
not easily cross the cell membrane (Stieber, Stöckl, Herrmann, Hassfurth, & Hofmann, 
2005), it is possible to determine the location of the HCN channels by applying the drug 
in the postsynaptic pipette (Horwitz, Risner-Janiczek, & Holt, 2014). ZD7288 only 
prevented the frequency increase when it was bath applied and, therefore, blocking 
presynaptic HCN channels. This suggests that the HCN channels responsible for 
forskolin’s effect are presynaptic.  
While our data strongly support our conclusion that presynaptic HCN channels mediate 
forskolin’s action on sEPSC frequency, HCN channels are also expressed in a portion of 
postsynaptic CRH neurons and may be important for other cell properties, such as the 
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postsynaptic excitability and/or synaptic integration. Whole-brain HCN in situ 
hybridization studies have identified high levels of HCN3 mRNA in the PVN, moderate 
levels of HCN 1 and HCN4 and low levels of HCN2 (Monteggia, Eisch, Tang, 
Kaczmarek, & Nestler, 2000). In contrast, single-cell RT-mPCR data shows that HCN1, 
HCN2, and HCN3 were present in cells that were electrophysiologically identified as 
parvocellular neurons (Qiu et al., 2005). Egli, Berger, & Imboden (2002) found that the Ih 
exists in 59 % of electrophysiologically identified parvocellular PVN neurons, although 
they did not distinguish between autonomic and neurosecretory subtypes. Using our 
CRH-reporter mouse line, we were able to confirm that a portion (approximately 50%) of 
parvocellular CRH-secreting neurons possess HCN channels by the identification of the 
characteristic “voltage sag” (the slight depolarization in response to hyperpolarization in 
current clamp; see Fig. 3.4 C). Importantly, the postsynaptic sag was blocked when 
ZD7288 was applied through the pipette, confirming that the drug was blocking 
postsynaptic HCN channels. Despite the postsynaptic HCN blockade, ZD7288 
application through the pipette was not sufficient to block forskolin’s effect, suggesting 
the HCN channels involved in forskolin-induced frequency increase are located on the 
presynaptic terminals.  
We propose that forskolin increases cAMP in afferent presynaptic terminals, which binds 
to and opens HCN channels. Presynaptic HCN channels have been found to facilitate 
synaptic transmission in two ways: 1) HCN channels depolarize synaptic terminals, 
thereby decreasing the threshold for action-potential generation and increasing the 
frequency of spontaneous action potential-dependent EPSCs, as has been shown in the 
cerebellum, basolateral amygdala and CA1 region of the hippocampus (He et al., 2014; 
Park et al., 2011; Southan, Morris, Stephens, & Robertson, 2000); 2) HCN channels can 
be located near release machinery and cause a depolarization that activates high-threshold 
voltage-gated P/Q-type Ca2+ channels thereby facilitating neurotransmitter release. This 
action potential-independent form of HCN-induced facilitation has been found in the 
dentate gyrus and Calyx of Held (Aponte, Lien, Reisinger, & Jonas, 2006; Awatramani, 
Price, & Trussell, 2005). Further experiments are needed to determine the exact 
mechanism through which HCN channels increase sEPSC frequency in CRH neurons, 
but it is possible that both mechanisms are at work, as forskolin drives both action 
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potential-dependent and -independent EPSCs. A future direction for this project is to 
investigate forskolin’s effect in the presence of ZD7288 and TTX to block action 
potential-dependent release. 
Experiments in other systems have revealed similar roles for HCN channels in 
presynaptic transmission. In substantia gelintinosa neurons, ZD7288 decreased sEPSC 
and mEPSC frequency through a presynaptic mechanism and partially inhibited the 
forskolin-induced increase in mEPSC frequency for excitatory but not inhibitory 
transmission (Peng et al., 2017). It was also reported that HCN channels underlie a form 
of LTP that requires a presynaptic cAMP/PKA-dependent mechanism in hippocampal 
mossy fibers (Mellor, Nicoll, & Schmitz, 2002). This finding was quickly contradicted by 
Chevaleyre & Castillo (2002), who showed that presynaptic HCN channels are not 
involved in mossy-fiber LTP. The role of HCN channels in presynaptic forms of LTP has 
yet to be determined, but this controversy has prompted investigation into the specificity 
of HCN channel blockers. 
4.4 ZD7288 specificity  
Our conclusion that forskolin acts through HCN channels to increase the frequency is 
based on the pharmacology and specificity of the antagonist ZD7288. Although ZD7288 
is generally considered to be a specific antagonist for HCN channels, some non-specific 
effects have been reported at higher concentrations. ZD7288 has been shown to block T-
type Ca2+ channels in the hippocampus with an IC50 of 40 μM (Sánchez-Alonso et al., 
2008), suggesting a small portion of these channels could be blocked at the low 
concentration we used (15 μM) and possibly a significant amount at the higher 
concentration (70 μM). To rule out the possibility that ZD7288 was blocking sEPSC 
frequency through T-type Ca2+ channels, we applied forskolin in the presence of Ni2+ 
(500 μM–1 mM), which is known to specifically block T-type Ca2+ channels (Mlinar & 
Enyeart, 1993; Todorovic & Lingle, 1998). Unlike ZD7288, Ni2+ had no effect on the 
forskolin-induced frequency increase, suggesting ZD7288 was not acting through T-type 
Ca2+ channels. In another study, ZD7288 was found to block Na+ channels in dentate 
granule cells and HEK cells transfected with Nav1.4 (Wu et al., 2012). Blockade of Na
+ 
channels would be expected to decrease sEPSC frequency; however, this is unlikely as 
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Nav1.4 channels are not expressed in the PVN (Feetham, O’Brien, & Barrett-Jolley, 
2018), and this effect of ZD7288 has not been reproduced in any other brain area or on 
any other Na+ channel subtypes.  
HCN channels are known to be sensitive to Cs+ in the extracellular medium, which 
blocks HCN channels in the low mM range (1–6 mM; Southan, Morris, Stephens, & 
Robertson, 2000). We attempted to use Cs+ to verify that forskolin acts through HCN 
channels. Unfortunately, this experiment was inconclusive as Cs+ had non-specific effects 
that increased the frequency of sEPSC and made it impossible to analyse forskolin’s 
effect.  In addition to blocking HCN channels, Cs+ potently blocks various types of 
voltage-dependent K+ channels. In slice patch clamp recordings from CRH neurons, we 
have shown that blocking K+ channels (as seen in the 4AP experiment and Salter et al. 
(2018)) causes a robust increase in the sEPSC frequency. This action of Cs+ would mask 
any effect of blocking HCN channels (which is expected to decrease sEPSC frequency). 
For this reason, we cannot conclude from our data whether cesium’s block of HCN 
channels affected forskolin’s action. Recently, Ivabraine has been suggested to be a more 
useful HCN channel blocker, as it lacks effects on Na+, Ca2+ and K+ currents; however, it 
has been reported that it is selective for HCN4 (Romanelli et al., 2016), which may have 
low expression in the PVN (Qiu et al., 2005). Regardless, further experiments are needed 
to test the selectivity of ZD7288 on HCN channels in CRH neurons. 
4.5 Modulation of HCN channels by cAMP via GPCRs 
It has been proposed based on the structure and anatomy of the PVN, that CRH neurons 
are under heterosynaptic modulation; the phenomenon where one transmitter system 
affects neighbouring systems (Bains, Wamsteeker Cusulin, & Inoue, 2015). This is based 
on the low spine density of CRH dendrites and the mixed organization of 
neurotransmitter contacts. For example, innervation of the PVN by noradrenaline 
afferents can modulate GABAergic synaptic transmission to CRH neurons (Inoue et al., 
2013). This is even more promising with the knowledge that glutamate and GABA 
synapses in the PVN co-release other neurotransmitters and peptides (Johnson et al., 
2018). This model fits well with our data as we have shown that activation of adenylyl 
cyclase positively modulates glutamatergic transmission to CRH neurons. Therefore, it is 
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possible that neurotransmitters that activate adenylyl cyclase (namely through stimulatory 
GPCRs) are capable of augmenting glutamatergic synapses to CRH neurons. This is 
supported by our finding that serotonin application in the PVN increased the frequency of 
glutamatergic sEPSCs in CRH neurons. This type of mechanism has been shown in the 
crayfish neuromuscular junction, where cAMP modulation of presynaptic HCN channels 
by serotonin enhanced synaptic transmission (Beaumont & Zucker, 2000).  It is also 
possible that intra-PVN microcircuits are modulated by HCN channels expressed in 
parvocellular PVN neurons. Electrophysiologically identified parvocellular neurons 
showed a positive shift in the Ih in response to angiotensin (which is GPCR-coupled) 
application (Egli et al., 2002) and parvocellular PVN neurons have been shown to 
organize into intra-PVN circuits that modulate HPA axis activation (Jiang, 
Rajamanickam, & Justice, 2018). In contrast, α2-adrenoreceptor agonists suppressed Ih in 
parvocellular neurons, which was weakly modulated by cAMP (Shirasaka, Ph, Kannan, 
& Takasaki, 2007), suggesting cAMP levels can bidirectionally influence HCN channels 
and their effect on synaptic transmission.  
4.6 ERK pathway 
Although forskolin is commonly known to activate PKA and/or EPAC pathways, our 
data suggests that forskolin’s effect on the frequency was independent of these common 
pathways. A third target downstream of cAMP is the extra cellular regulated kinase 
pathway (ERK; Emery & Eiden, 2012). The ERK pathway (also known as the MAPK 
pathway) is a kinase cascade pathway that activates transcription of a variety of genes but 
has also been shown to increase neurotransmitter release through its interaction with 
synapsin (Riganti et al., 2016; Vara, Onofri, Benfenati, Sassoè-Pognetto, & Giustetto, 
2009). Due to its role in presynaptic release, we cannot rule out the possibility that 
blocking ERK decreased sEPSC frequency independently of forskolin. Considering the 
fact that the ERK inhibitor U0126 decreased the baseline frequency before application of 
forskolin, ERK signaling may indeed be required for presynaptic release rather than 
upregulated by forskolin. At this time, more experiments are needed to investigate the 
role of ERK in forskolin-induced frequency increase. 
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4.7 Sensitization at the level of CRH afferents 
Our mouse model of chronic stress, RRS, causes habituation at the level of the CRH 
neurons as shown by a reduction in c-Fos immunoreactivity and as a decrease in the 
intrinsic excitability. Importantly, following RRS, subsequent exposure to novel stress 
(e.g., cold swim) recovers c-Fos immunoreactivity despite the CRH neurons’ habituation. 
This points to two distinct forms of plasticity, that decrease sensitivity to homotypic 
stressors while also maintaining a normal response to novel stressors.  In the present 
study, we found that CRH neurons from mice exposed to the same RRS paradigm, show 
a greater capacity for synaptic activity at the level of the CRH afferents. This finding is 
similar to Kusek and colleagues (2013)’s finding that sEPSC frequency was greater after 
RRS. One difference was that the previous study revealed a stress-induced difference at 
baseline, whereas the present study only showed a trend towards a baseline frequency 
increase after RRS. As the activity of afferent inputs to CRH neurons determines their 
activity (and subsequent HPA axis activation), this increased capacity may compensate 
for habituation by increasing the response to incoming stress signals. Specifically, we 
found that the stress-induced synaptic change was only evident when synapses were 
driven (by forskolin) to a high level of activity and not at the baseline. This could suggest 
that exposure to a novel stressor, which would elicit high afferent stress activity to the 
PVN, would cause a greater response in CRH neurons after RRS. This finding supported 
our hypothesis that stress sensitization could manifest as an upregulation of neural circuit 
upstream of CRH neurons. However, further experiments are needed to show a causal 
link between this plasticity and hormonal or behavioural sensitization of HPA axis 
responses. Interestingly, our effect was not found to be an overall increase in synaptic 
activity (as shown by 4-AP experiments), but rather a difference in the response to 
cAMP-dependent activity, which may hint as to how a novel stressor is “coded” at the 
level of the PVN. In support of this theory, Gaillet, Lachuer, Malaval, Assenmacher, & 
Szafarczyk (1991) propose that specific neurotransmitter pathways (e.g., noradrenaline) 
represent specific types of stressors (Pacak & Palkovitis, 2001).  
Our data revealed that presynaptic HCN channels partially mediate the effects of 
forskolin on glutamatergic transmission to CRH neurons. Interestingly, HCN channels 
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have been found to undergo plasticity in response to chronic stress in other brain areas. 
Chronic stress increases HCN-mediated currents in the hippocampus and prefrontal 
cortex (Arnsten, 2011; Kim et al., 2017) but decreases HCN-mediated currents in the 
ventral tegmental area (Zhong et al., 2018), which was found to increase anxiety and 
depression behaviour. In line with these studies our data suggest that chronic stress 
causes HCN channel plasticity. Specifically, we propose that RRS upregulates the Ih, 
thereby increasing the capacity for forskolin-induced sEPSC increase through HCN 
channels. Future studies should attempt to pinpoint the nature of the HCN channel 
plasticity. Genetic approaches that modulate HCN channel expression can also be used to 
determine to what extent HCN channels modulate behavioural responses to stress in vivo. 
We believe the mechanism identified in the present study supports the ability of the HPA 
axis to respond normally (or in a sensitized manner) to a novel stressor despite being 
habituated to chronic stress.  
4.8 Conclusion 
This study identified a form of chronic stress-induced synaptic plasticity that could 
support sensitization of the HPA axis. We found that RRS potentiated glutamatergic 
afferents to CRH neurons, which manifests as a sensitization of these synapses to 
stimulation by the cAMP activator, forskolin. As our recent work showed that the 
intrinsic excitability of CRH neurons decreases after RRS (Inoue et al., 2017), the 
potentiated afferent activity may serve to overcome the decreased CRH neuron 
excitability when responding to novel stress. Specifically, we found that the response to 
the forskolin-induced increase in sEPSC frequency was greater after RRS, and this RRS-
induced synaptic potentiation was lost in the presence of the HCN channel antagonist 
ZD7288. Our data also indicate that the HCN channels targeted by ZD7288 are located 
on presynaptic terminals and facilitate the release of glutamate upon cAMP signaling. 
The ability of the HPA axis to undergo experience-dependent activity and habituate to 
chronic stress is a key mechanism that allows animals to conserve energy and prevent the 
detrimental effects of chronic glucocorticoid exposure. However, it is not adaptive to 
have a “downregulated” stress response if a novel stressor is encountered; therefore, a 
mechanism that allows the stress response to overcome habituation and respond to 
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unfamiliar stressors is vital to the survival of the animal. These data identify a possible 
mechanism and further our understanding of this important form of plasticity.  
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